HEALTHCARE & MEDICARE
-
The case for true interoperability with universal medical coders
The healthcare industry is once again entering a period of heightened expectations for interoperability. Federal agencies are stepping up enforcement…
Read More » -
Bayer lung cancer drug gets fast FDA approval to stay competitive with Boehringer Ingelheim Med
A Bayer drug designed to target tumors driven by rare genetic mutations has received accelerated FDA approval, providing another treatment…
Read More » -
Millie launches artificial intelligence solution for maternity care
Women's health clinic Millie launched a new artificial intelligence agent on Tuesday aimed at providing more personalized support for maternity…
Read More » -
Increase supply chain resilience to tariffs and disruptions
The healthcare industry often operates in a state of constant disruption. From global pandemics to geopolitical instability, supply chains are…
Read More » -
Power of One: Redefining Healthcare with a Unified Platform Powered by AI
The average healthcare practice relies on numerous vendors to manage its IT infrastructure. This intricate web of contracts, systems, and…
Read More » -
As FDA approves RNAi drug, Arrowhead Pharma begins price war with rival Ionis
An RNA drug from Arrowhead Pharmaceuticals has passed regulatory standards to treat a disease that causes dangerous levels of fat…
Read More » -
The most scientifically advanced cryopreservation technology: Alcor is at the forefront
Cryonics has moved from the world of science fiction to a real-world pursuit, with the belief that future medicine may…
Read More » -
Struggling UnitedHealth Group is a giant smoking black box – Healthcare Blog
Author: Jeff Goldsmith In mid-April 2025, UnitedHealth Group (UNH) announced operating results for the first quarter of 2025, which included…
Read More » -
How Sanford Health is embedding artificial intelligence into its EHR to detect disease early and provide personalized care
Electronic health records hold so much patient data that clinicians often struggle to extract the data that really matters at…
Read More » -
J&J's $3 billion acquisition of Halda offers a way to overcome drug resistance in prostate cancer and more
Johnson & Johnson acquired Halda Therapeutics for $3.05 billion to expand its oncology product line. Halda Therapeutics is a startup…
Read More »